EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Trans-Atlantic Differences in Approach to Sudden Death Prevention in Patients With Hypertrophic Cardiomyopathy

Max Liebregts

Canadian Journal of Cardiology · 2024

DOI: 10.1016/j.cjca.2024.03.011 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Canadian Journal of Cardiology, 2024. Verfasst von Max Liebregts. Beteiligte Einrichtung: Department of Cardiology, St Antonius Hospital, Nieuwegein, The Netherlands. Electronic address: maxliebregts@gmail.com. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Death, Sudden, Cardiac. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The American approach to predicting sudden cardiac death (SCD) in patients with hypertrophic cardiomyopathy diverges from the European method in that it relies on major risk factors independently justifying the implantation of an implantable cardioverter-defibrillator for primary prevention, whereas the European approach uses a mathematical equation to estimate a 5-year risk percentage. The aim of this review is to outline the differences between the American and European guidelines and to show how they have arisen. Furthermore, it will provide insight into the future of SCD risk prediction in patients with hypertrophic cardiomyopathy. The American SCD risk prediction method has high sensitivity but limited specificity, whereas the European method has the opposite. These differences in sensitivity and specificity likely contribute to the fact that primary prevention implantable cardioverter-defibrillator utilization is twofold higher in the United States. It is highly likely that new insights and new imaging modalities will enhance prediction models in the near future. Genotyping could potentially assume a significant role. Left ventricular global longitudinal strain was recently shown to be an independent predictor of SCD. Furthermore, after late gadolinium enhancement, additional cardiac magnetic resonance techniques such as T1 mapping and diffusion tensor imaging are showing encouraging outcomes in predicting SCD. Ultimately, it is conceivable that integrating diverse morphological and genetic characteristics through deep learning will yield novel insights and enhance SCD prediction methods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, HypertrophicDeath, Sudden, CardiacHumansEuropePrimary PreventionUnited StatesRisk AssessmentDefibrillators, ImplantableRisk Factors

Autor:innen und Institutionen

  • Department of Cardiology, St Antonius Hospital, Nieuwegein, The Netherlands. Electronic address: maxliebregts@gmail.com.

Zitieren

APA

Liebregts, M. (2024). Trans-Atlantic Differences in Approach to Sudden Death Prevention in Patients With Hypertrophic Cardiomyopathy. Canadian Journal of Cardiology. https://doi.org/10.1016/j.cjca.2024.03.011

Vancouver

Liebregts M. Trans-Atlantic Differences in Approach to Sudden Death Prevention in Patients With Hypertrophic Cardiomyopathy. Canadian Journal of Cardiology. 2024. doi:10.1016/j.cjca.2024.03.011

BibTeX
@article{Liebregts2024,
  author = {Liebregts, Max},
  title = {Trans-Atlantic Differences in Approach to Sudden Death Prevention in Patients With Hypertrophic Cardiomyopathy},
  journal = {Canadian Journal of Cardiology},
  year = {2024},
  doi = {10.1016/j.cjca.2024.03.011}
}
Kostenlos starten →